SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 518 (1) , 127-133
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- LncRNA SNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR‐4500 and targeting STAT3Journal of Cellular Biochemistry, 2019
- Long noncoding RNA MALAT1 suppresses breast cancer metastasisNature Genetics, 2018
- MALAT1 induces osteosarcoma progression by targeting miR‐206/CDK9 axisJournal of Cellular Physiology, 2018
- Molecular Mechanisms Linking Exercise to Cancer Prevention and TreatmentCell Metabolism, 2018
- LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancerCancer Gene Therapy, 2017
- Long non‐coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA‐125b/STAT3 axisJournal of Cellular Physiology, 2017
- Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapyNature Reviews Endocrinology, 2017
- Osteosarcoma OverviewRheumatology and Therapy, 2016
- An update on chemotherapy for osteosarcomaExpert Opinion on Pharmacotherapy, 2015
- MicroRNAs and other non-coding RNAs as targets for anticancer drug developmentNature Reviews Drug Discovery, 2013